Replies to post #3687 on Repros Therapeutics Inc (RPRX)

[exwannabe]

RE: Outright manipulation

My post was in jest.

[Nerf]

I think things are finally starting to roll with this one. Time to see the double digits again, soon, IMO

[quantumdot]

He was joking. Jeez, for a smart guy you miss some pretty obvious cues.

Glad to see the company specifically address the dose selection for the PhIII in today's "newsy" PR. Just maybe some of the questions and discussion about dose selection that offended several on this board got through to the company? And just maybe they saw fit to address them, including the specific reference "These data also support the selection of the doses of 25 and 50 mg in our Phase 3 trials."

Perhaps open debate and dialogue of some of the issues can help surface extra information or clarification from the company. IMO, the defensive types on the board should embrace such posting threads rather than feel so threatened by them.